Natural Health Trends (NHTC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
Annual meeting scheduled for May 7, 2026, in Hong Kong, with voting available online or in person.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of four directors: Randall A. Mason, Chris T. Sharng, Ellen Sun, and Ching C. Wong.
Approval of the 2026 Equity Incentive Plan is up for vote.
Ratification of CBIZ CPAS P.C. as independent auditor for the year ending December 31, 2026.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and incentive plan.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Natural Health Trends
- Q2 2026 sales fell 23% to $7.6M as regulatory and economic uncertainty persisted.NHTC
Q2 2026 - Q1 2026 revenue dropped 14% year-over-year, with a net loss of $154,000 and 75% gross margin.NHTC
Q1 2026 - Shareholders will vote on director elections, a new equity plan, and auditor ratification.NHTC
Proxy filing - Annual meeting to elect directors, approve equity plan, and ratify auditor, with focus on governance.NHTC
Proxy filing - Q4 revenue up 3% sequentially; $1.5M in annual savings and $0.10 dividend declared.NHTC
Q4 2025 - Q3 2024 sales up 1% to $10.7M, net income $35K, and $0.20 dividend declared.NHTC
Q3 2024 - Flat Q2 sales, improved profit, and Hong Kong's first sales growth since Q1 2023.NHTC
Q2 2024 - Revenue down 2% year-over-year, orders up 9%, $0.20 dividend declared, trade risks persist.NHTC
Q1 2025 - Q4 2024 revenue flat, Greater China up 7%, net income $176K, $9.2M dividends paid.NHTC
Q4 2024